Biological agents in head and neck cancer

Authors: Bossi, Paolo; Locati, Laura D; Licitra, Lisa

Source: Expert Review of Anticancer Therapy, Volume 7, Number 11, November 2007 , pp. 1643-1650(8)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Survival of head and neck cancer (HNC) patients has not dramatically improved over the last 30 years, despite the advances in surgical techniques, chemotherapeutic agents and radiotherapy treatment planning and definition. Different studies in molecular biology of HNC have been carried out, providing useful results for clinical application. HNC usually includes malignant tumors arising from mucosa of the upper aerodigestive tract, from nasopharynx to larynx/trachea, while salivary gland and thyroid cancers are less frequently listed in this classification. In this review, we chose to provide a comprehensive review of the role of biological agents in head and neck subsites. Molecular characteristics and treatment-relevant signaling pathways will be briefly discussed along with the results of the more recent clinical studies that include biological agents.

Keywords: biological agents; clinical trials; head and neck cancer; molecular basis

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14737140.7.11.1643

Publication date: 2007-11-01

More about this publication?

Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites